- Home
- ICLR vs FNF Comparison
ICLR vs FNF Comparison
Compare ICLR & FNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- FNF
- Stock Information
- Founded
- ICLR 1990
- FNF 1847
- Country
- ICLR Ireland
- FNF United States
- Employees
- ICLR N/A
- FNF N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- FNF Specialty Insurers
- Sector
- ICLR Health Care
- FNF Finance
- Exchange
- ICLR Nasdaq
- FNF Nasdaq
- Market Cap
- ICLR 13.7B
- FNF 16.0B
- IPO Year
- ICLR 1998
- FNF N/A
- Fundamental
- Price
- ICLR $173.13
- FNF $58.46
- Analyst Decision
- ICLR Buy
- FNF Strong Buy
- Analyst Count
- ICLR 15
- FNF 5
- Target Price
- ICLR $209.93
- FNF $71.20
- AVG Volume (30 Days)
- ICLR 1.1M
- FNF 1.0M
- Earning Date
- ICLR 10-22-2025
- FNF 11-05-2025
- Dividend Yield
- ICLR N/A
- FNF 3.33%
- EPS Growth
- ICLR 13.11
- FNF 16.93
- EPS
- ICLR 9.73
- FNF 3.93
- Revenue
- ICLR $8,089,820,000.00
- FNF $13,634,000,000.00
- Revenue This Year
- ICLR N/A
- FNF $1.15
- Revenue Next Year
- ICLR $1.73
- FNF $10.81
- P/E Ratio
- ICLR $17.51
- FNF $15.27
- Revenue Growth
- ICLR N/A
- FNF 7.26
- 52 Week Low
- ICLR $125.10
- FNF $50.61
- 52 Week High
- ICLR $310.54
- FNF $66.72
- Technical
- Relative Strength Index (RSI)
- ICLR 51.75
- FNF 51.35
- Support Level
- ICLR N/A
- FNF N/A
- Resistance Level
- ICLR $176.07
- FNF $60.97
- Average True Range (ATR)
- ICLR 6.17
- FNF 1.02
- MACD
- ICLR -7.19
- FNF -2.42
- Stochastic Oscillator
- ICLR 94.78
- FNF 95.21
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About FNF FNF Group of Fidelity National Financial Inc.
Fidelity National Financial Inc is a provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty and (ii) transaction services to the real estate and mortgage industries. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. Substantially all of the company's revenue is generated in the United States.